EW logo

Edwards Lifesciences (EW) Revenue

Annual Revenue

$5.44 B
-$565.30 M-9.41%

December 1, 2024

Summary

Performance

1-Year Change

-9.41%

3-Year Change

+3.96%

5-Year Change

+25.1%

15-Year Change

+58.34%

EW Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

92.41%
EW annual revenue is higher than 92.41% of companies in Healthcare sector

Analysts Estimate

$5.82 B
EW annual revenue is currently -6.48% lower than the consensus analysts' forecast

High & Low

All-time High

$6.00 B
EW annual revenue is currently -9.41% below its historical high of $6.00 billion

3-Year Low

$5.23 B
EW annual revenue is currently +3.96% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2024
EW previous annual earnings announcement was published on Dec 1, 2024

Next Annual Earnings Report Date

N/A
EW next annual earnings announcement has not yet been scheduled

OtherEWprofitabilitymetrics:

Annual EPS

$6.97
EW annual earnings per share is $6.97

Annual Net Income

$4.17 B
EW annual net profit is $4.17 billion

Annual Operating Profit

$1.48 B
EW annual operating income is $1.48 billion

Annual Gross Profit

$4.32 B
EW annual gross profit is $4.32 billion

Quarterly Revenue

$1.39 B
+$31.40 M+2.32%

December 1, 2024

Summary

Performance

3-Month Change

+2.32%

1-Year Change

+2.32%

3-Year Change

+2.32%

5-Year Change

+2.32%

EW Quarterly Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

91.37%
EW quarterly revenue is higher than 91.37% of companies in Healthcare sector

Analysts Estimate

$1.40 B
EW quarterly revenue is currently -1.08% lower than the consensus analysts' forecast

High & Low

All-time High

$2.26 B
EW quarterly revenue is currently -38.71% below its historical high of $2.26 billion

3-Year Low

$1.24 B
EW quarterly revenue is currently +11.45% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 1, 2024
EW previous earnings announcement was published on Dec 1, 2024

Next Quarterly Earnings Report Date

Apr 25, 2025
EW next earnings announcement is scheduled for Apr 25, 2025

Related metrics

Quarterly Gross Profit

$1.09 B
EW quarterly gross profit is $1.09 billion

Quarterly Operating Profit

$353.30 M
EW quarterly operating income is $353.30 million

Quarterly Net Income

$385.60 M
EW quarterly net profit is $385.60 million

Quarterly EPS

$0.65
EW quarterly earnings per share is $0.65

TTM Revenue

$5.72 B
-$875.40 M-13.26%

December 1, 2024

Summary

Performance

3-Month Change

-13.26%

1-Year Change

-13.26%

3-Year Change

-13.26%

5-Year Change

-13.26%

EW TTM Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

91.74%
EW TTM revenue is higher than 91.74% of companies in Healthcare sector

Analysts Estimate

$5.53 B
EW TTM revenue is currently +3.57% higher than the consensus analysts' forecast

High & Low

All-time High

$6.60 B
EW TTM revenue is currently -13.26% below its historical high of $6.60 billion

3-Year Low

$5.23 B
EW TTM revenue is currently +9.40% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 1, 2024
EW previous earnings announcement was published on Dec 1, 2024

Next Quarterly Earnings Report Date

Apr 25, 2025
EW next earnings announcement is scheduled for Apr 25, 2025

OtherEWprofitabilitymetrics:

TTM Gross Profit

$4.50 B
EW TTM gross profit is $4.50 billion

TTM Operating Profit

$1.56 B
EW TTM operating income is $1.56 billion

TTM Net Income

$4.17 B
EW TTM net profit is $4.17 billion

TTM EPS

$6.97
EW TTM earnings per share is $6.97

EW Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-9.4%+2.3%-13.3%
3 y3 years+4.0%+2.3%-13.3%
5 y5 years+25.1%+2.3%-13.3%

EW Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-9.4%+4.0%-38.7%+11.4%-13.3%+9.4%
5 y5-year-9.4%+25.1%-38.7%+49.8%-13.3%+32.5%
alltimeall time-9.4%+685.9%-38.7%+837.6%-13.3%+2432.9%

Edwards Lifesciences Revenue History

DateAnnualQuarterlyTTM
Dec 2024
$5.44 B(-9.4%)
$1.39 B(+2.3%)
$5.72 B(-13.3%)
Sep 2024
-
$1.35 B(-2.3%)
$6.60 B(+1.7%)
Jun 2024
-
$1.39 B(-13.3%)
$6.49 B(+1.4%)
Mar 2024
-
$1.60 B(-29.3%)
$6.40 B(+2.2%)
Dec 2023
$6.00 B(+11.6%)
$2.26 B(+81.9%)
$6.26 B(+17.1%)
Sep 2023
-
$1.24 B(-4.0%)
$5.35 B(-1.4%)
Jun 2023
-
$1.30 B(-11.2%)
$5.42 B(-1.4%)
Mar 2023
-
$1.46 B(+8.3%)
$5.50 B(+2.2%)
Dec 2022
$5.38 B(+2.9%)
$1.35 B(+2.2%)
$5.38 B(+0.3%)
Sep 2022
-
$1.32 B(-4.0%)
$5.36 B(+0.2%)
Jun 2022
-
$1.37 B(+2.4%)
$5.36 B(-0.0%)
Mar 2022
-
$1.34 B(+0.9%)
$5.36 B(+2.4%)
Dec 2021
$5.23 B(+19.3%)
$1.33 B(+1.5%)
$5.23 B(+2.7%)
Sep 2021
-
$1.31 B(-4.8%)
$5.09 B(+3.4%)
Jun 2021
-
$1.38 B(+13.1%)
$4.93 B(+10.1%)
Mar 2021
-
$1.22 B(+2.1%)
$4.47 B(+2.0%)
Dec 2020
$4.39 B(+0.9%)
$1.19 B(+4.5%)
$4.39 B(+0.4%)
Sep 2020
-
$1.14 B(+23.3%)
$4.37 B(+1.1%)
Jun 2020
-
$925.00 M(-18.0%)
$4.32 B(-3.6%)
Mar 2020
-
$1.13 B(-3.9%)
$4.48 B(+3.1%)
Dec 2019
$4.35 B(+16.8%)
$1.17 B(+7.3%)
$4.35 B(+4.7%)
Sep 2019
-
$1.09 B(+0.7%)
$4.15 B(+4.7%)
Jun 2019
-
$1.09 B(+9.5%)
$3.96 B(+3.7%)
Mar 2019
-
$993.00 M(+1.6%)
$3.82 B(+2.6%)
Dec 2018
$3.72 B(+8.4%)
$977.70 M(+7.8%)
$3.72 B(+2.5%)
Sep 2018
-
$906.60 M(-3.9%)
$3.63 B(+2.4%)
Jun 2018
-
$943.70 M(+5.5%)
$3.55 B(+3.0%)
Mar 2018
-
$894.80 M(+0.7%)
$3.45 B(+0.3%)
Dec 2017
$3.44 B(+15.9%)
$888.50 M(+8.2%)
$3.44 B(+3.6%)
Sep 2017
-
$821.50 M(-2.4%)
$3.31 B(+2.5%)
Jun 2017
-
$841.80 M(-4.7%)
$3.23 B(+2.6%)
Mar 2017
-
$883.50 M(+15.1%)
$3.15 B(+6.3%)
Dec 2016
$2.96 B(+18.8%)
$767.70 M(+3.8%)
$2.96 B(+3.4%)
Sep 2016
-
$739.40 M(-2.6%)
$2.87 B(+4.5%)
Jun 2016
-
$759.30 M(+8.9%)
$2.74 B(+5.5%)
Mar 2016
-
$697.30 M(+3.9%)
$2.60 B(+4.3%)
Dec 2015
$2.49 B(+7.4%)
$671.10 M(+9.0%)
$2.49 B(+2.2%)
Sep 2015
-
$615.50 M(-0.2%)
$2.44 B(+0.3%)
Jun 2015
-
$616.80 M(+4.5%)
$2.43 B(+1.7%)
Mar 2015
-
$590.30 M(-4.5%)
$2.39 B(+2.9%)
Dec 2014
$2.32 B(+13.6%)
$618.00 M(+1.7%)
$2.32 B(+3.7%)
Sep 2014
-
$607.40 M(+5.6%)
$2.24 B(+5.3%)
Jun 2014
-
$575.10 M(+10.1%)
$2.13 B(+2.8%)
Mar 2014
-
$522.40 M(-2.5%)
$2.07 B(+1.3%)
Dec 2013
$2.05 B(+7.7%)
$536.00 M(+8.2%)
$2.05 B(+1.3%)
Sep 2013
-
$495.60 M(-4.2%)
$2.02 B(+2.4%)
Jun 2013
-
$517.20 M(+4.1%)
$1.97 B(+1.8%)
Mar 2013
-
$496.70 M(-2.7%)
$1.94 B(+2.0%)
Dec 2012
$1.90 B
$510.50 M(+14.0%)
$1.90 B(+4.4%)
Sep 2012
-
$447.90 M(-7.1%)
$1.82 B(+2.0%)
DateAnnualQuarterlyTTM
Jun 2012
-
$482.00 M(+5.0%)
$1.78 B(+2.9%)
Mar 2012
-
$459.20 M(+6.7%)
$1.73 B(+3.3%)
Dec 2011
$1.68 B(+16.0%)
$430.20 M(+4.2%)
$1.68 B(+2.3%)
Sep 2011
-
$412.70 M(-4.3%)
$1.64 B(+4.0%)
Jun 2011
-
$431.20 M(+6.6%)
$1.58 B(+4.4%)
Mar 2011
-
$404.50 M(+3.1%)
$1.51 B(+4.4%)
Dec 2010
$1.45 B(+9.5%)
$392.40 M(+12.5%)
$1.45 B(+3.3%)
Sep 2010
-
$348.90 M(-4.5%)
$1.40 B(+1.7%)
Jun 2010
-
$365.20 M(+7.3%)
$1.38 B(+2.2%)
Mar 2010
-
$340.50 M(-1.8%)
$1.35 B(+2.0%)
Dec 2009
$1.32 B(+6.8%)
$346.70 M(+6.4%)
$1.32 B(+2.9%)
Sep 2009
-
$325.70 M(-2.9%)
$1.28 B(+1.8%)
Jun 2009
-
$335.50 M(+7.0%)
$1.26 B(+0.6%)
Mar 2009
-
$313.50 M(+1.2%)
$1.25 B(+1.3%)
Dec 2008
$1.24 B(+13.4%)
$309.70 M(+2.0%)
$1.24 B(+1.4%)
Sep 2008
-
$303.60 M(-7.3%)
$1.22 B(+3.6%)
Jun 2008
-
$327.60 M(+10.4%)
$1.18 B(+4.9%)
Mar 2008
-
$296.80 M(+1.3%)
$1.12 B(+3.0%)
Dec 2007
$1.09 B(+5.2%)
$293.00 M(+12.1%)
$1.09 B(+2.6%)
Sep 2007
-
$261.40 M(-4.1%)
$1.06 B(+1.3%)
Jun 2007
-
$272.60 M(+3.2%)
$1.05 B(+0.5%)
Mar 2007
-
$264.10 M(-0.6%)
$1.04 B(+0.7%)
Dec 2006
$1.04 B(+3.9%)
$265.60 M(+7.4%)
$1.04 B(+1.6%)
Sep 2006
-
$247.40 M(-7.4%)
$1.02 B(+0.6%)
Jun 2006
-
$267.30 M(+4.0%)
$1.01 B(+0.9%)
Mar 2006
-
$257.00 M(+2.9%)
$1.01 B(+0.8%)
Dec 2005
$997.90 M(+7.1%)
$249.70 M(+3.7%)
$997.90 M(+1.3%)
Sep 2005
-
$240.90 M(-6.7%)
$985.30 M(+1.7%)
Jun 2005
-
$258.20 M(+3.7%)
$969.20 M(+2.5%)
Mar 2005
-
$249.10 M(+5.1%)
$945.60 M(+1.5%)
Dec 2004
$931.50 M(+8.3%)
$237.10 M(+5.5%)
$931.50 M(+1.4%)
Sep 2004
-
$224.80 M(-4.2%)
$918.50 M(+2.1%)
Jun 2004
-
$234.60 M(-0.2%)
$899.80 M(+1.9%)
Mar 2004
-
$235.00 M(+4.9%)
$883.00 M(+2.6%)
Dec 2003
$860.50 M(+22.2%)
$224.10 M(+8.7%)
$860.50 M(+2.5%)
Sep 2003
-
$206.10 M(-5.4%)
$839.50 M(+5.0%)
Jun 2003
-
$217.80 M(+2.5%)
$799.20 M(+6.0%)
Mar 2003
-
$212.50 M(+4.6%)
$754.20 M(+7.1%)
Dec 2002
$704.00 M(+1.7%)
$203.10 M(+22.5%)
$704.00 M(+6.5%)
Sep 2002
-
$165.80 M(-4.1%)
$660.90 M(+2.8%)
Jun 2002
-
$172.80 M(+6.5%)
$642.90 M(-3.0%)
Mar 2002
-
$162.30 M(+1.4%)
$662.50 M(-4.3%)
Dec 2001
$692.10 M(-13.9%)
$160.00 M(+8.3%)
$692.10 M(-7.5%)
Sep 2001
-
$147.80 M(-23.2%)
$748.60 M(-4.8%)
Jun 2001
-
$192.40 M(+0.3%)
$786.60 M(-1.6%)
Mar 2001
-
$191.90 M(-11.4%)
$799.20 M(-4.1%)
Dec 2000
$804.00 M(-11.2%)
$216.50 M(+16.5%)
$833.30 M(+35.1%)
Sep 2000
-
$185.80 M(-9.4%)
$616.80 M(+43.1%)
Jun 2000
-
$205.00 M(-9.3%)
$431.00 M(+90.7%)
Mar 2000
-
$226.00 M
$226.00 M
Dec 1999
$905.00 M
-
-

FAQ

  • What is Edwards Lifesciences annual revenue?
  • What is the all time high annual revenue for Edwards Lifesciences?
  • What is Edwards Lifesciences annual revenue year-on-year change?
  • What is Edwards Lifesciences quarterly revenue?
  • What is the all time high quarterly revenue for Edwards Lifesciences?
  • What is Edwards Lifesciences quarterly revenue year-on-year change?
  • What is Edwards Lifesciences TTM revenue?
  • What is the all time high TTM revenue for Edwards Lifesciences?
  • What is Edwards Lifesciences TTM revenue year-on-year change?

What is Edwards Lifesciences annual revenue?

The current annual revenue of EW is $5.44 B

What is the all time high annual revenue for Edwards Lifesciences?

Edwards Lifesciences all-time high annual revenue is $6.00 B

What is Edwards Lifesciences annual revenue year-on-year change?

Over the past year, EW annual revenue has changed by -$565.30 M (-9.41%)

What is Edwards Lifesciences quarterly revenue?

The current quarterly revenue of EW is $1.39 B

What is the all time high quarterly revenue for Edwards Lifesciences?

Edwards Lifesciences all-time high quarterly revenue is $2.26 B

What is Edwards Lifesciences quarterly revenue year-on-year change?

Over the past year, EW quarterly revenue has changed by +$31.40 M (+2.32%)

What is Edwards Lifesciences TTM revenue?

The current TTM revenue of EW is $5.72 B

What is the all time high TTM revenue for Edwards Lifesciences?

Edwards Lifesciences all-time high TTM revenue is $6.60 B

What is Edwards Lifesciences TTM revenue year-on-year change?

Over the past year, EW TTM revenue has changed by -$875.40 M (-13.26%)